- Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report
-
So D, Min KW, Jung WY, Han SW, Yu MY
- KMID: 2529777
- J Korean Med Sci.
- 2022 May;37(19):e154.
- doi: 10.3346/jkms.2022.37.e154
Coronavirus disease 2019 (COVID-19) is one of the most widespread viral infections in human history. As a breakthrough against infection, vaccines have been developed to achieve herd immunity. Here, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Cerebral Venous Thrombosis without Thrombocytopenia after COVID-19 Vaccination
-
Hwang J, Sohn JH, Lee SH, Lee E, Jeon W, Kim Y
- KMID: 2529609
- J Korean Neurol Assoc.
- 2022 May;40(2):160-163.
- doi: 10.17340/jkna.2022.2.10
Cerebral venous thrombosis (CVT) is a rare form of cerebrovascular attack and its predisposing factors commonly co-exist. In the coronavirus disease 2019 (COVID-19) era, various side effects of COVID-19 vaccine... -
- CITED
-
- Close
- SHARE
-
- Close
- Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
-
Kwon SR, Kwon SR, Kim N, Park H, Minn D, Park S, Roh EY, Yoon JH, Shin S
- KMID: 2529768
- J Korean Med Sci.
- 2022 May;37(19):e135.
- doi: 10.3346/jkms.2022.37.e135
Despite strict guidelines for coronavirus disease 2019 (COVID-19), South Korea is facing its fourth pandemic wave. In this study, by using an automated electrochemiluminescence immunoassay assay, we tracked anti-spike protein... -
- CITED
-
- Close
- SHARE
-
- Close
- Short Term Impact of Coronavirus Disease 2019 Vaccination in Children in Korea
-
Lee H, Choi EH, Park YJ, Choe YJ
- KMID: 2529700
- J Korean Med Sci.
- 2022 May;37(17):e124.
- doi: 10.3346/jkms.2022.37.e124
Background: The epidemiology of coronavirus disease 2019 (COVID-19) has changed continuously throughout the pandemic. Methods: We analyzed changes in the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection according... -
- CITED
-
- Close
- SHARE
-
- Close
- Delphi Survey for COVID-19 Vaccination in Korean Children Between 5 and 11 Years Old
-
Choe YJ, Lee YH, Choi JH
- KMID: 2529862
- Pediatr Infect Vaccine.
- 2022 Apr;29(1):37-45.
- doi: 10.14776/piv.2022.29.e6
Purpose: During the coronavirus disease 2019 (COVID-19) pandemic, we conducted a Delphi survey that included the experts from the field of COVID-19 immunization in children aged 5–11 years. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review
-
Choi M, Yu SY, Cheong C, Choe YJ, Choi SH
- KMID: 2529861
- Pediatr Infect Vaccine.
- 2022 Apr;29(1):28-36.
- doi: 10.14776/piv.2022.29.e4
Purpose: To evaluate the efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines in children aged 5–11 years, a rapid systematic review was conducted on published clinical trials of COVID-19... -
- CITED
-
- Close
- SHARE
-
- Close
- Latest Overseas Policy on Coronavirus Disease 2019 Vaccination for Children Aged 5 to 11
-
Moon J, Choe YJ, Choi YY
- KMID: 2529859
- Pediatr Infect Vaccine.
- 2022 Apr;29(1):16-27.
- doi: 10.14776/piv.2022.29.e5
In Korea, children aged 5 to 11 have been vaccinated against coronavirus disease 2019 (COVID-19) from March 2022. Due to this age group not being at a high risk of... -
- CITED
-
- Close
- SHARE
-
- Close
- Dr. James Smith’s Dream of Eradicating Smallpox and the National Vaccine Institution
-
LEE HJ
- KMID: 2529818
- Korean J Med Hist.
- 2022 Apr;31(1):297-331.
- doi: 10.13081/kjmh.2022.31.297
This article re-examines from a new perspective the efforts of James Smith (1771–1841), a Maryland doctor, to eradicate smallpox in the United States. As one of the few successful cowpox... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined Treatment With Radiotherapy and Immunotherapy for Isocitrate Dehydrogenase Mutant Brainstem Glioma in Adult: A Case Report
-
Morimoto T, Matsuda R, Nakazawa T, Nishimura F, Nakagawa I
- KMID: 2529436
- Brain Tumor Res Treat.
- 2022 Apr;10(2):129-133.
- doi: 10.14791/btrt.2022.0009
Brainstem gliomas are not common in adults, and the treatment strategies and their outcomes are limited. Immunotherapy is emerging as a promising new modality for the treatment of these gliomas.... -
- CITED
-
- Close
- SHARE
-
- Close
- Hormone Therapy in the Era of the COVID-19 Pandemic: A Review
-
Choi SW, Kim J, Lee JH, Kim SK, Lee SR, Kim SH, Chae HD
- KMID: 2529879
- J Menopausal Med.
- 2022 Apr;28(1):1-8.
- doi: 10.6118/jmm.21036
The coronavirus disease 2019 (COVID-19) pandemic has impacted the medical, social, and reproductive health of millions of people since its outbreak. The causative virus transmits, reproduces, and manifests through the... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic
-
Mir I, Aamir S, Hussain Shah SR, Shahid M, Amin I, Afzal S, Nawaz A, Umer Khan M, Idrees M
- KMID: 2529730
- Osong Public Health Res Perspect.
- 2022 Apr;13(2):84-100.
- doi: 10.24171/j.phrp.2022.0024
The coronavirus disease 2019 (COVID-19) pandemic rapidly spread globally. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, is a positive-sense single-stranded RNA virus with a reported fatality rate... -
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 outbreak response at a nursing hospital in South Korea in the post-vaccination era, including an estimation of the effectiveness of the first shot of the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1-S)
-
Kim C, Kang G, Kang SG, Lee H
- KMID: 2529726
- Osong Public Health Res Perspect.
- 2022 Apr;13(2):114-122.
- doi: 10.24171/j.phrp.2021.0262
Objectives: We descriptively reviewed a coronavirus disease 2019 (COVID-19) outbreak at a nursing hospital in Gyeonggi Province (South Korea) and assessed the effectiveness of the first dose of the Oxford-AstraZeneca... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
-
Park S, You J
- KMID: 2529296
- J Korean Med Sci.
- 2022 Apr;37(16):e131.
- doi: 10.3346/jkms.2022.37.e131
Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report... -
- CITED
-
- Close
- SHARE
-
- Close
- Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
-
Kang SH, Kim MY, Cho MY, Baik SK
- KMID: 2528174
- J Korean Med Sci.
- 2022 Apr;37(15):e116.
- doi: 10.3346/jkms.2022.37.e116
Autoimmune hepatitis (AIH) is a chronic, autoimmune disease of the liver that occurs when the body’s immune system attacks liver cells, causing the liver to be inflamed. AIH is one... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination
-
Kim SH, Lee SY, Kim GY, Oh JS, Kim J, Chun KJ, Ju MH, Lee Ch, Song YJ, Na JY
- KMID: 2527830
- J Korean Med Sci.
- 2022 Apr;37(13):e104.
- doi: 10.3346/jkms.2022.37.e104
Vaccines have become the mainstay of management against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019; COVID-19) in the absence of effective antiviral therapy. Various adverse effects... -
- CITED
-
- Close
- SHARE
-
- Close
- Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer
-
Adin ME, Wu J, Isufi E, Tsui E, Pucar D
- KMID: 2529352
- J Breast Cancer.
- 2022 Apr;25(2):140-144.
- doi: 10.4048/jbc.2022.25.e12
Vaccine-related axillary nodal enlargement is a common benign condition that many mRNA vaccine receivers experience. However, a false attribution of axillary swelling to vaccination may result in delay in cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review
-
Lee JK, Shin OS
- KMID: 2529266
- J Yeungnam Med Sci.
- 2022 Apr;39(2):89-97.
- doi: 10.12701/jyms.2021.01669
More than 2 years after the explosion of the coronavirus disease 2019 (COVID-19) pandemic, extensive efforts have been made to develop safe and efficacious vaccines against infections with severe acute... -
- CITED
-
- Close
- SHARE
-
- Close
- SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
-
Lee YJ, Kim SE, Park YE, Chang JY, Song HJ, Kim DH, Yang YJ, Kim BC, Lee JG, Yang HC, Choi M, Myung SJ, The Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases (KASID)
- KMID: 2529563
- Intest Res.
- 2022 Apr;20(2):171-183.
- doi: 10.5217/ir.2021.00098
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, is threatening global health worldwide with unprecedented contagiousness and severity. The best strategy to overcome COVID-19 is a vaccine. Various vaccines... -
- CITED
-
- Close
- SHARE
-
- Close
- Designing a novel mRNA vaccine against Vibrio harveyi infection in fish: an immunoinformatics approach
-
Islam SI, Mou MJ, Sanjida S, Tariq M, Nasir S, Mahfuj S
- KMID: 2527954
- Genomics Inform.
- 2022 Mar;20(1):e11.
- doi: 10.5808/gi.21065
Vibrio harveyi belongs to the Vibrio genus that causes vibriosis in marine and aquatic fish species through double-stranded DNA virus replication. In humans, around 12 Vibrio species can cause gastroenteritis... -
- CITED
-
- Close
- SHARE
-
- Close
- Sleep and vaccine administration time as factors influencing vaccine immunogenicity
-
Kim ES, Oh CE
- KMID: 2527692
- Kosin Med J.
- 2022 Mar;37(1):27-36.
- doi: 10.7180/kmj.22.014
The immunogenicity of vaccines is affected by host, external, environmental, and vaccine factors; in addition, sleep or circadian rhythms may also have effects. With the use of vaccines to mitigate... -
- CITED
-
- Close
- SHARE
-
- Close
